期刊文献+

闭环胰岛素输送系统的研究进展

Research Progress in Closed-loop Insulin Delivery Systems
原文传递
导出
摘要 1型糖尿病和进展型2型糖尿病患者胰岛素分泌不足,表现出高血糖症状。为了维持血糖正常,这些糖尿病患者需每天多次注射胰岛素。然而,胰岛素的需求受饮食、运动、疾病等多重因素影响,加之胰岛素本身治疗指数极窄,因此胰岛素剂量难以估算准确,若胰岛素注射过量可危及生命。此外,每日多次注射胰岛素给患者带来了较大的生理和心理负担。为了解决以上问题,研究人员着手开发闭环胰岛素输送系统,使胰岛素剂量能够依据糖尿病患者实时血糖水平变化进行调整,从而提升控制血糖的安全性和有效性。本综述按照闭环胰岛素输送系统的组成属性,将闭环胰岛素输送系统分为电子类闭环胰岛素输送系统和剂型类闭环胰岛素输送系统。从2种闭环胰岛素输送系统的组成元件、发展历程、临床应用、目前优劣以及后续的发展方向等几个方面进行阐述,着重对比了两类闭环胰岛素输送系统的相对优势。 Individuals with type 1 diabetes or advanced type 2 diabetes suffer insufficient insulin secretion,leading to symptoms of hyperglycemia.To maintain the normal blood glucose levels,those people with diabetes must administer insulin multiple times a day.However,insulin requirements are influenced by several factors such as diet,exercise,and illness,combined with the narrow therapeutic index,making accurate insulin dosage challenging.Excessive insulin administration can even pose life-threatening risks.In addition,frequent daily insulin injections place considerable physiological and psychological burdens on patients.To tackle these challenges,researchers have embarked on the development of closed-loop insulin delivery systems.These systems adjust insulin dosages in real-time changes based on the patient’s blood glucose levels,therefore enhancing both the safety and effectiveness of insulin therapy.This review categorizes closed-loop insulin delivery systems into two types:electronic-based and material-based systems,based on their compositional attributes.The exploration of both types covers their components,developmental history,clinical applications,current pros and cons,and future directions.The relative strengths and limitations of these two categories of closed-loop insulin delivery systems are also compared and discussed.
作者 魏翔骞 张秀雯 王延芳 魏鑫伟 张娟 季康凡 张世明 顾臻 王金强 WEI Xiangqian;ZHANG Xiuwen;WANG Yanfang;WEI Xinwei;ZHANG Juan;JI Kangfan;ZHANG Shiming;GU Zhen;WANG Jinqiang(Key Laboratory of Advanced Drug Delivery Systems of Zhejiang Province,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China;Department of Electrical and Electronic Engineering the University of Hong Kong,Hong Kong 999077,China;Jinhua Institute of Zhejiang University,Jinhua 321299,China;National Key Laboratory of Advanced Drug Delivery and Release Systems,Zhejiang University,Hangzhou 310058,China;Zhejiang University Medical Center,Liangzhu Laboratory,Hangzhou 311121,China;MOE Key Laboratory of Macromolecular Synthesis and Functionalization,Department of Polymer Science and Engineering,Zhejiang University,Hangzhou 310027,China;Department of General Surgery,Sir Run Run Shaw Hospital,School of Medicine,Zhejiang University,Hangzhou 310016,China;Department of Pharmacy,Second Affiliated Hospital,Zhejiang University School of Medicine,Zhejiang University,Hangzhou 310009,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2024年第10期1303-1312,共10页 Chinese Journal of Modern Applied Pharmacy
基金 国家重点研发计划项目(2022YFE0202200)。
关键词 药物递送 闭环治疗 胰岛素输送系统 1型糖尿病 糖响应 drug delivery closed-loop therapies insulin delivery system type 1 diabetes glucose responsive
  • 相关文献

参考文献2

二级参考文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部